Skip to main content
Clinical Trials/NL-OMON43832
NL-OMON43832Not yet recruitingPhase 4

Oral steroids for the treatment of inflammatory Complex Regional Pain Syndrome type-1 - OSTI

Sint Elisabeth Ziekenhuis0 sites52 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Not yet recruiting
Sponsor
Enrollment
52

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • 1. CRPS-1 (clinical Budapest criteria) in one arm only.
  • 2. Inflammatory type: painful upper extremity, temperature difference, swelling, red
  • discoloration, limited hand function.
  • 3. Occurring after trauma or upper extremity surgery
  • 4. Acute stadium of less than 12 months duration
  • 5. Diminished functioning of the upper extremity as established by a DASH score of 10 or more (Hudak, 1996)
  • 6. Average pain score of 3 or more on a one week pain diary, three times daily
  • 7. No indication for surgical therapy or no future surgery planned
  • 8. Age 18-80

Exclusion Criteria

  • not able to comply with follow up visits
  • <18 or > 80 years of age
  • more than one extremity involved
  • body temperature of > 38 degrees Celsius
  • Elevated white blood cell count ( > 10-E9/liter)
  • Elevated BSE and CRP
  • Associated Infectious disease
  • Coagulation disorders, use of anticoagulants
  • untreated peptic ulcer, hypertension, untreated diabetes, untreated cardiac failure

Investigators

Sponsor
Sint Elisabeth Ziekenhuis

Similar Trials